HIV News and Research

RSS

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Many doctors caution their pregnant patients to avoid cat feces; even the family pet's litter box is off-limits. Now, a group of researchers from Clemson University have discovered a promising therapy for those who suffer from toxoplasmosis, a disease caused by the microscopic protozoa Toxoplasma gondii.

11 May 2022

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

A six-year study of nearly 100,000 women in Botswana has provided new evidence that relatively inexpensive daily diet supplementation of iron, folic acid and vitamin supplementation in pregnancy can reduce complications at birth.

11 May 2022

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system.

11 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

Study investigates antibody-mediated response against different SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on antibody-mediated immunity.

10 May 2022

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020.

9 May 2022

New genetic markers could improve early detection of drug-resistant tuberculosis

To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year.

9 May 2022

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Researchers reported on a three-layer designer deoxyribonucleic acid (DNA) nanostructure (DDN) strategy-based sensor designed by them for rapid and accurate SARS-CoV-2 detection and inhibition.

9 May 2022

Differences in COVID-19 outcomes related to sex

Researchers looked at gender variations in COVID-19 outcomes such as hospitalization, ICU admission, mortality, and heart damage.

9 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

3 May 2022

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

CDC will hold its annual Epidemic Intelligence Service Conference May 2-5, 2022, via a virtual platform that is free and open to the public.

3 May 2022

Mexico City Policy may be associated with higher maternal, child mortality and HIV incidence rates

Restricting US foreign aid for non-governmental organizations (NGOs) that provide information on or access to abortion-related services in developing countries may have harmful effects on maternal and child mortality and HIV incidence rates on the same scale as an ongoing civil conflict.

2 May 2022

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk of organ failure, kidney problems, or death compared with placebo, although numerically fewer participants treated with dapagliflozin experienced these outcomes. The findings are published in CJASN.

29 Apr 2022

HIV News and Research

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Study investigates antibody-mediated response against different SARS-CoV-2 variants

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

New genetic markers could improve early detection of drug-resistant tuberculosis

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Differences in COVID-19 outcomes related to sex

Evaluation of the potential of new and repurposed TB vaccines

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

Mexico City Policy may be associated with higher maternal, child mortality and HIV incidence rates

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Sen. Orrin Hatch’s legacy tracks the GOP’s evolution on health

Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News